Oncology Ventures
Actively deployingNew York · 18 people tracked
Investment thesis
Oncology Ventures invests in data-driven healthcare technologies that transform cancer care across the patient journey. The firm targets the fragmented and expensive U.S. oncology system by funding companies addressing early detection, precision diagnostics, care navigation, survivorship support, and the non-drug infrastructure needed for effective treatment. The thesis is grounded in the observation that outdated workflows, misaligned incentives, and data gaps create barriers to guideline-based care and evidence-based treatment optimization.
Source: firm website, verified Jul 20, 2026.
Team · 18 people
from the firm's websiteHealthcare technology investor with experience at Optum Ventures and Alpha Partners; co-builder of Thyme Care, a value-based cancer care company; cancer survivor with six years cancer-free. Holds BSc in Economics from Duke University.
Former CEO and current Vice Chairman of The Oncology Institute (NASDAQ: TOI), which manages care for 2+ million patients. Led company's 2021 Nasdaq IPO with ~$1 billion market capitalization; prior healthcare investor with TA Associates and General Atlantic. MBA from Stanford.
CEO of Flatiron Health focused on transforming real-world patient data into cancer research and care insights. Previously held senior roles at data and technology companies and was principal at Boston Consulting Group. MBA from Northwestern Kellogg School of Management.
Physician leading strategic direction of cancer hospital; practices as gynecologic oncologist. NCI-funded scientist with patents and 300+ peer-reviewed publications; serves as editor-in-chief of leading subspecialty journal.
Healthcare executive focused on community oncology growth and operations. Held senior leadership roles for 20+ years at McKesson and US Oncology Network; served as Chief Growth Officer at DispatchHealth. Master's degree from Harvard University.
Co-founder of Threshold Ventures backing healthcare and consumer companies including BetterUp, Calibrate, and Vital. Forbes Midas Brink List member and founding member of All Raise; currently Chairperson of National Venture Capital Association. MBA from Stanford University.
Leads innovation and government relations at City of Hope. Previous executive roles at UnitedHealth Group, Towers Watson, and Anthem; serves as Chairman of Board for AccessHope and on multiple healthcare advisory boards.
Chief Operating Officer of Texas Oncology overseeing operations and finance. Previously Chief Financial Officer for US Oncology Network and served 18 years at McKesson in provider technologies, clinical operations, and senior leadership roles in UK.
Partner emeritus of New York-based accounting firm (24 years); founded and leads financial planning and investment management firm since 1986 through Onyx Bridge Wealth Group. CPA and CFP with leadership roles in accounting professional organizations and judge for NYU Entrepreneurs Challenge.
Physician with 15+ years in value-based care, oncology, and precision medicine. Former Chief Medical Officer of Optum Health Solutions; launched Anthem's Cancer Care Quality Program. Currently advises healthcare organizations and life sciences companies on innovative care models and AI-enabled solutions.
Manager of Venture Studio at Atlantic Health leading innovation through strategic partnerships and venture development. Works with clinical leaders to identify high-impact opportunities; brings healthcare technology and clinical systems background to health system innovation.
CEO of Parker Institute for Cancer Immunotherapy, a national network developing cancer therapeutics. Former CEO of American Cancer Society and Executive Vice President of Oncology at Jefferson Health; serves on boards at AstraZeneca and multiple biotech companies.
Operations and project management professional with 15+ years across healthcare, technology, public policy, and research. Pursues joint MBA through Oxford Saïd and Metis College; holds bachelor's degree in Anthropology from University of the Philippines.
Physician and former Chief Medical Officer of UnitedHealth Group (11 years) who led oncology care advancement and value-based payment initiatives. Practiced medical oncology for nine years and currently serves on boards at Myriad Genetics, Coherus Bioscience, and Cellworks.
General Partner at Oak HC/FT focused on growth equity and early-stage healthcare venture investments. Serves on boards of Firefly Health, Maven, and other healthcare companies; previous executive roles at McKesson, athenahealth, and Harvard Community Health Plan.
Oncology strategy and operations professional who led digital product development and partnerships at Memorial Sloan Kettering; previously advised community oncology practices on digital health at Flatiron Health. Holds Master of Health Administration from Columbia University.
Deputy COO and Chief Strategy Officer at Fred Hutch leading business development and strategic planning. Previously Vice President of Cancer Services at UChicago Medicine; held strategy roles at UCSF Health and New York-Presbyterian Hospital.
Leads business development and innovation strategy at Moffitt Cancer Center with nearly 30 years of experience in marketing and operations. Most recently Chief Business Officer at Capricor Therapeutics; held leadership roles at Genentech and Gilead Sciences.
What they invest in
from 2 of 15 portfolio companiesAI & Machine Learning ×2Healthtech ×2Biotech ×1Medical Devices ×1SaaS ×1
HQs:United States×2
Investments · 15 tracked
founders shown can be your intro pathModicus Prime provides an AI Management System (AIMS) for pharmaceutical companies and contract development and manufacturing organizations (CDMOs) to validate, audit, and govern AI systems across their operations in compliance with FDA and other regulatory requirements.
AI & Machine LearningBiotechHealthtechSaaSLa Porte, US
Taylor Chartier(Founder & CEO)
Triomics builds AI systems for oncology teams that read full patient records and produce structured, auditable outputs for trial matching, visit preparation, and data curation. The company serves oncology clinics, trial matching networks, and quality reporting teams.
AI & Machine LearningHealthtechMedical DevicesNew York City, US
Sarim Khan(Co-Founder and CEO)inHrituraj Singh(Co-Founder and CTO)in
Frequently asked questions
- What sectors does Oncology Ventures focus on?
- Oncology Ventures focuses on Digital Health, Healthtech.
- Where is Oncology Ventures located?
- Oncology Ventures is headquartered in New York, US.
Similar investors
Breyer Capital invests in breakthrough biomedical technologies, emerging models of care, and economic systems that drive sustainable healthcare transformation. The firm partners early and deeply with entrepreneurs across AI-first diagnostics, programmable medicines, data infrastructure, financial systems, clinician software, and novel care delivery models.
Capricorn Partners is an independent, partner-owned management company established in 1993 that invests in innovative companies with positive impact on people and the planet, focusing on venture and growth capital across digital, health, and clean technologies primarily in Europe.
Data Collective identifies and supports ambitious company founders developing technology-driven solutions. The firm focuses on companies using innovation to restore predictability in an unstable world, with demonstrated expertise across clean energy, gene therapy, sustainable agriculture, and machine learning applications in healthcare.
FoundersX Ventures was founded in 2016 to invest in entrepreneurs building the future in enterprise AI, fintech, digital health, and biotech. The firm has backed 7 unicorns and 20+ portfolio companies valued over $100M.
Google Ventures invests in innovative founders across diverse industries, focusing on companies where they can provide value across multiple stages and milestones through long-term relationships.